LATEST NEWS | 21st Jul 2020 CEO Wayne Paterson is interviewed by Ausbiz

21st Jul 2020

CEO Wayne Paterson is interviewed by Ausbiz

20th Jul 2020

TAVR Key Opinion Leader Symposium

19th Jul 2020

Bioshares July 2020 Report

30th Mar 2020

Investor Q&A with Dr. Paul Sorajja & our CEO

Latest News

CEO Wayne Paterson is interviewed by Ausbiz

The $5 billion market for valves to treat aortic stenosis, the most common heart valve disease, has the potential to double by 2025. CEO of Anteris Technologies, Wayne Paterson, was live with us and says the key points of difference for the Anteris valve are the anti-calcification feature and unique design. This innovation avoids the need for open-heart surgery, reducing the amount of time it requires for a patient to recover.

21st Jul 2020

TAVR Key Opinion Leader Symposium

Full Video & CEO Presentation Deck

20th Jul 2020

Bioshares July 2020 Report

Anteris Technologies TAVR Advisory Board Signals High Level Interest

19th Jul 2020

Anteris Technologies delivering on its goals despite pandemic

Anteris Technologies Ltd's (ASX:AVR) Wayne Paterson tells Proactive's Andrew Scott the recent name change from Admedus is to reflect the single focus they have on structural heart and leveraging its assets into much more higher-value propositions. Paterson updates on its main trials which are underway and says he's extremely thrilled with the results to date from its first-in-human study. Paterson's expecting the company will end the year achieving all milestones set for 2020.

5th Jul 2020

ShareCafe's Hidden Gems Webinar – Anteris (AVR)

Latest video outlining Anteris direction to build the World's Most Durable Heart Valve

15th Jun 2020

StockPal Interview with Wayne Paterson

Anteris Technologies (ASX:AVR) – Wayne Paterson

4th Jun 2020

Bioshares - Admedus Name Change

Admedus has changed its name to Anteris Technologies

31st May 2020

Company Name Change

Change of company name from Admedus to Anteris Technologies

26th May 2020

Admedus 2020 AGM

Admedus 2020 AGM Video

14th May 2020

CEO Wayne Paterson is interviewed by Proactive Investors

CEO Wayne Paterson is interviewed by proactive investors to provide an update on Admedus in light of COVID-19

6th Apr 2020

First patient implanted with DurAVR™

Admedus implants first patient with their 3D single piece aortic valve

31st Mar 2020

Investor Q&A with Dr. Paul Sorajja & our CEO

Dr. Paul Sorajja shares his view on Admedus' TAVR

30th Mar 2020